Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 13
Submit an article Journal homepage
398
Views
3
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Evaluation

A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer

Mohamad Moussaa Department of Urology, Al Zahraa Hospital, University Medical Center, Lebanese University, Beirut, LebanonView further author information
,
Athanasios Papatsorisb 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
View further author information
,
Despoina Sryropoulouc Department of Radiation Oncology, University of Patras, Patras, GreeceView further author information
,
Mohamed Abou Chakraa Department of Urology, Al Zahraa Hospital, University Medical Center, Lebanese University, Beirut, LebanonView further author information
,
Athanasios Dellisb 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece;d Department of Surgery, School of Medicine, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, GreeceView further author information
&
Lazaros Tzelvesb 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, GreeceView further author information
Pages 1685-1728 | Received 26 Nov 2020, Accepted 30 Apr 2021, Published online: 02 Jun 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Iraklis Mitsogiannis, Lazaros Tzelves, Athanasios Dellis, Hussein Issa, Athanasios Papatsoris & Mohammad Moussa. (2022) Prostate cancer immunotherapy. Expert Opinion on Biological Therapy 22:5, pages 577-590.
Read now

Articles from other publishers (2)

Fiona Y.‐V. Pham, Emmanuelle Jacquet, Amina Taleb, Adrien Monard, Ghania Kerouani‐Lafaye, Florence Turcry, Liora Brunel, Françoise Grudé, Isabelle Yoldjian, Isabelle Sainte‐Marie, Lotfi Boudali, Jean‐Yves Blay & Nicolas Albin. (2022) Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. International Journal of Cancer 151:8, pages 1345-1354.
Crossref
Igor Tsaur, Anita Thomas, Michelle Monecke, Marion Zugelder, Jochen Rutz, Timothy Grein, Sebastian Maxeiner, Hui Xie, Felix K.-H. Chun, Florian Rothweiler, Jindrich CinatlJr.Jr., Martin Michaelis, Axel Haferkamp & Roman A. Blaheta. (2022) Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells. Cancers 14:13, pages 3111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.